Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1758-9193
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease ; volume:10 ; number:1 ; day:28 ; month:8 ; year:2018 ; pages:1-9 ; date:12.2018
Alzheimer's research & therapy ; 10, Heft 1 (28.8.2018), 1-9, 12.2018

Urheber
Beteiligte Personen und Organisationen
Gaignaux, Amélie
Kofanova, Olga
Ermann, Natalia
Betsou, Fay
Brandner, Sebastian
Mroczko, Barbara
Blennow, Kaj
Strapagiel, Dominik
Paciotti, Silvia
Vogelgsang, Jonathan
Roehrl, Michael H.
Mendoza, Sandra
Kornhuber, Johannes
Teunissen, Charlotte
SpringerLink (Online service)

DOI
10.1186/s13195-018-0418-3
URN
urn:nbn:de:101:1-2018102000082903123595
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:20 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Lewczuk, Piotr
  • Gaignaux, Amélie
  • Kofanova, Olga
  • Ermann, Natalia
  • Betsou, Fay
  • Brandner, Sebastian
  • Mroczko, Barbara
  • Blennow, Kaj
  • Strapagiel, Dominik
  • Paciotti, Silvia
  • Vogelgsang, Jonathan
  • Roehrl, Michael H.
  • Mendoza, Sandra
  • Kornhuber, Johannes
  • Teunissen, Charlotte
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease

Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress

Der N-Methyl-D-Aspartat (NMDA)-Rezeptor im menschlichen Gehirn : experimentelle Studien unter besonderer Berücksichtigung der Schizophrenien

Hochschulschrift

Der N-Methyl-D-Aspartat (NMDA)-Rezeptor im menschlichen Gehirn : experimentelle Studien unter besonderer Berücksichtigung der Schizophrenien

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Fluid biomarkers in Alzheimer’s disease – current concepts

Fluid biomarkers in Alzheimer’s disease – current concepts

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Diversitätsintelligenz

Diversitätsintelligenz

Verbundene Objekte